Basic information
- Name:
Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride(1:1)
- Superlist Name:
- Labetalol hydrochloride
- CAS No.:
32780-64-6
- Molecular Structure:
![Molecular Structure of 32780-64-6 (Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride(1:1))](http://www.lookchem.com/300w/2010/0620/32780-64-6.jpg)
- Formula:
- C19H24N2O3.ClH
- Molecular Weight:
- 364.87
- Synonyms:
- Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-,monohydrochloride (9CI);Salicylamide,5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, monohydrochloride(8CI);5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride;Amipress;Ipolab;Labelol;Labracol;Normodyne;Presdate;Pressalolo;Trandate;Vescal;
- EINECS:
- 251-211-1
- Boiling Point:
- 552.7 °C at 760 mmHg
- Flash Point:
- 288.1 °C
- Hazard Symbols:
Xn- Risk Codes:
- 22
- Safety Description:
- 36 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Specification
The CAS registry number of Labetalol hydrochloride is 32780-64-6. Its EINECS registry number is 251-211-1. The IUPAC name is 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide hydrochloride. In addition, the molecular formula is C19H24N2O3.ClH and the molecular weight is 364.87. What's more, it should be stored in sealed container, and put them in a cool and dry place.
Physical properties about this chemical are: (1)ACD/LogP: 2.31; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): -0.66; (4)ACD/LogD (pH 7.4): 0.56; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 7.69; (9)#H bond acceptors: 5; (10)#H bond donors: 5; (11)#Freely Rotating Bonds: 10; (12)Polar Surface Area: 42.01 Å2; (13)Flash Point: 288.1 °C; (14)Enthalpy of Vaporization: 87.69 kJ/mol; (15)Boiling Point: 552.7 °C at 760 mmHg; (16)Vapour Pressure: 4.75E-13 mmHg at 25°C.
When you are using this chemical, please be cautious about it as the following:
This chemical is harmful if swallowed. When you are using it, wear suitable protective clothing.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C(c1cc(ccc1O)C(O)CNC(C)CCc2ccccc2)N.Cl
(2)InChI: InChI=1/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H
(3)InChIKey: WQVZLXWQESQGIF-UHFFFAOYAA
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | oral | > 1500mg/kg (1500mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: ATAXIA GASTROINTESTINAL: NAUSEA OR VOMITING | Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 6, Pg. 273, 1980. |
| man | LDLo | oral | 1620mg/kg/27W (1620mg/kg) | GASTROINTESTINAL: OTHER CHANGES KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION | Annals of Internal Medicine. Vol. 113, Pg. 210, 1990. |
| mouse | LD50 | intraperitoneal | 114mg/kg (114mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Hokkaido Igaku Zasshi. Hokkaido Journal of Medical Science. Vol. 53, Pg. 15, 1978. |
| mouse | LD50 | intravenous | 47mg/kg (47mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Hokkaido Igaku Zasshi. Hokkaido Journal of Medical Science. Vol. 53, Pg. 15, 1978. |
| mouse | LD50 | oral | 1450mg/kg (1450mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Hokkaido Igaku Zasshi. Hokkaido Journal of Medical Science. Vol. 53, Pg. 15, 1978. |
| rabbit | LD50 | intravenous | 41mg/kg (41mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA | Hokkaido Igaku Zasshi. Hokkaido Journal of Medical Science. Vol. 53, Pg. 15, 1978. |
| rabbit | LD50 | oral | 1250mg/kg (1250mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Hokkaido Igaku Zasshi. Hokkaido Journal of Medical Science. Vol. 53, Pg. 15, 1978. |
| rat | LD50 | intraperitoneal | 107mg/kg (107mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Hokkaido Igaku Zasshi. Hokkaido Journal of Medical Science. Vol. 53, Pg. 15, 1978. |
| rat | LD50 | intravenous | 53mg/kg (53mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Hokkaido Igaku Zasshi. Hokkaido Journal of Medical Science. Vol. 53, Pg. 15, 1978. |
| rat | LD50 | oral | 2114mg/kg (2114mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 21, Pg. 6307, 1987. |
| women | LDLo | oral | 244mg/kg/76D- (244mg/kg) | LIVER: LIVER FUNCTION TESTS IMPAIRED LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | American Journal of Medicine. Vol. 87, Pg. 235, 1989. |
| women | LDLo | oral | 360mg/kg/60D- (360mg/kg) | Annals of Internal Medicine. Vol. 113, Pg. 210, 1990. | |
| women | LDLo | oral | 360mg/kg/60D- (360mg/kg) | LIVER: LIVER FUNCTION TESTS IMPAIRED | Annals of Internal Medicine. Vol. 113, Pg. 210, 1990. |
| women | TDLo | oral | 53mg/kg/53D-I (53mg/kg) | Annals of Internal Medicine. Vol. 113, Pg. 210, 1990. | |
| women | TDLo | oral | 53mg/kg/53D-I (53mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Annals of Internal Medicine. Vol. 113, Pg. 210, 1990. |

